SCHEMBL3822674

SCHEMBL3822674

Cc1cccc(-n2nc(C)c(CN)c2C)c1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
L3MBTL1 Q9Y468 3/20 0.43
MAPT P10636 3/20 0.43
LMNA P02545 2/20 0.43
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
P2RX7 Q99572 2/20 0.42
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3823086 0.98 ALDH1A1 (0.53) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL3828501 0.80 NPC1 (0.57) NPC1RAB9AP2RX7TSHR
SCHEMBL11653918 0.79 SMN1; SMN2 (0.69) ALDH1A1KMT2ANPC1RAB9AL3MBTL1
SCHEMBL23402128 0.76 ALDH1A1 (0.54) ALDH1A1NPC1RAB9AL3MBTL1MAPT
SCHEMBL25540605 0.76 ALDH1A1 (0.54) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL23398379 0.74 ALDH1A1 (0.49) ALDH1A1NPC1RAB9AL3MBTL1MAPT
SCHEMBL23399745 0.74 ALDH1A1 (0.45) ALDH1A1NPC1RAB9AL3MBTL1MAPT
SCHEMBL13172605 0.73 ALDH1A1 (0.64) ALDH1A1KMT2ANPC1RAB9AL3MBTL1
SCHEMBL25540866 0.73 ALDH1A1 (0.51) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL3822672 0.73 RIPK2 (0.59) ALDH1A1NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP claimed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US claimed
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF PYGL, GYS2, G6PC1 ALDH1A1 775/4885KMT2A 3325/4885MEN1 3728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.